Brookline Capital Markets Starts Assertio Therapeutics (ASRT) at Buy

June 2, 2020 4:16 PM EDT
Get Alerts ASRT Hot Sheet
Price: $1.26 --0%

Rating Summary:
    7 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 6 | Down: 6 | New: 9
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Brookline Capital Markets analyst Sally Yanchus initiates coverage on Assertio Therapeutics (NASDAQ: ASRT) with a Buy rating and a price target of $3.50.

For an analyst ratings summary and ratings history on Assertio Therapeutics click here. For more ratings news on Assertio Therapeutics click here.

Shares of Assertio Therapeutics closed at $1.00 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage